FactMR today released its latest report on the Veterinary Endoscopy Market, providing comprehensive insights into the global market’s significant growth driven by the rising demand for minimally invasive diagnostics and treatments in animal healthcare. Valued at USD 206.4 million in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 5.9%, reaching USD 386.7 million by 2035. This expansion, representing a 1.8X increase with an incremental dollar opportunity of USD 168.7 million, underscores the critical role of veterinary endoscopy in enhancing diagnostic accuracy and patient outcomes for companion and large animals.

Market Outlook and Growth Projections

The global veterinary endoscopy market is set for robust growth from 2025 to 2035, fueled by increasing adoption of endoscopic procedures in veterinary medicine. Veterinary endoscopy, encompassing flexible, videoscope, fibreoptic, rigid, and other endoscopes, enables precise diagnosis and treatment of conditions such as gastrointestinal, respiratory, and oncological diseases with minimal invasiveness. The report projects the market to grow from USD 206.4 million in 2024 to USD 386.7 million by 2035, with a CAGR of 5.9%. This growth is driven by technological advancements, rising pet ownership, and increasing demand for livestock health management, creating substantial opportunities for manufacturers and veterinary practitioners.

Key Drivers Fueling Market Demand

The primary drivers of the veterinary endoscopy market include the growing popularity of minimally invasive procedures, which offer quicker recovery and fewer complications, as noted in posts on X highlighting the humanization of pets and rising veterinary costs. The increasing prevalence of gastrointestinal disorders in animals, such as inflammatory bowel disease and foreign body ingestion, drives demand for endoscopic diagnostics, with gastroduodenoscopy holding a significant revenue share of USD 53.7 million in 2023. Rising pet ownership, with 66% of U.S. households owning pets in 2024, and growing livestock production, particularly in North America and Europe, further boost the market. Technological advancements, such as high-definition videoscopes, AI-driven diagnostics, and capsule endoscopy, enhance procedural accuracy, while pet insurance coverage, with a 2.3% adoption rate for dogs in the U.S., makes advanced procedures more accessible.

Challenges and Restraints in the Sector

Despite its promising outlook, the market faces challenges. High costs of endoscopic equipment, such as Olympus Corporation’s EVIS EXERA III PCF-PH190L priced at USD 26,000, and procedures, averaging GBP 789 per session, limit affordability, particularly in developing regions. The report highlights the need for specialized training, as a lack of skilled veterinarians hinders adoption, with training programs requiring significant time and resources. Regulatory compliance and concerns over equipment sterilization, especially for reusable endoscopes, add operational complexities. Providers must focus on cost-effective solutions, such as portable fiberscopes, and expand training initiatives to overcome these barriers and ensure broader market penetration.

Segment-Wise Insights and Dominant Trends

The report provides detailed segmentation analysis, identifying flexible endoscopes as the dominant product segment, holding a 67% market share in 2023 due to their maneuverability for procedures like gastroscopy and colonoscopy. Videoscope endoscopes are the fastest-growing segment, with a projected CAGR of 8.2%, driven by real-time imaging capabilities. By animal type, companion animals lead, fueled by rising pet healthcare spending, while large animals, particularly cattle, are growing due to livestock disease monitoring. Clinics dominate end-use segments, with rapid adoption of portable endoscopic equipment. Key trends include AI-integrated videoscopes, with Fujifilm’s 2024 launch enhancing gastrointestinal diagnostics, and the rise of capsule endoscopy for non-invasive evaluations. Sustainable, single-use endoscopes are also gaining traction to reduce infection risks.

Regional Outlook and Growth Hotspots

North America holds the largest market share, with a 39.8% revenue share in 2023, driven by advanced veterinary infrastructure, high pet ownership, and major players like KARL STORZ and Olympus Corporation. Europe follows, with Germany, France, and the UK leading due to EU animal welfare regulations and advanced imaging adoption. The Asia-Pacific region is expected to exhibit the fastest growth, with a projected CAGR of 7.5%, fueled by improving veterinary infrastructure and rising pet populations in China and India. Latin America and the Middle East and Africa (MEA) are emerging markets, supported by government initiatives for livestock health. The report identifies Asia-Pacific as a key growth engine due to its expanding veterinary sector and increasing awareness of minimally invasive techniques.

Recent Developments

The veterinary endoscopy market has seen significant advancements in 2024 and early 2025. In April 2024, Fujifilm launched an AI-integrated videoscope, improving diagnostic accuracy for gastrointestinal procedures. In August 2024, Olympus Corporation partnered with a North American veterinary hospital chain to supply advanced endoscopic systems. In February 2025, KARL STORZ introduced a next-generation flexible endoscope for small animal diagnostics, enhancing image clarity and usability. Posts on X highlight innovations like OmniVision’s OH02B image sensor for reusable and disposable endoscopes, launched in November 2022. Additionally, IMV Technologies’ 2022 acquisition of VES Custom Optics strengthened its companion animal endoscopy portfolio. These developments reflect the market’s shift toward AI-driven and sustainable solutions.

Key Players Insights

Leading players in the veterinary endoscopy market are driving innovation through R&D and strategic partnerships. KARL STORZ SE & Co. KG leads with a diverse portfolio, including EquiVeo video endoscopes, while Olympus Corporation excels in high-definition imaging. Fujifilm Holdings Corporation and Biovision Veterinary Endoscopy, LLC focus on AI integration and niche solutions. Other key players, including Dr. Fritz GmbH, Eickemeyer Veterinary Equipment Ltd., B. Braun Melsungen AG, and STERIS Corporation, are expanding their offerings with portable and cost-effective systems. These companies, holding a 50-55% market share, are pursuing acquisitions and collaborations, such as Olympus’s 2024 hospital chain partnership, to strengthen their global presence, with strong growth projected through 2035.

Competitive Landscape

The market features a competitive ecosystem with key players driving innovation and market share. Companies profiled include KARL STORZ SE & Co. KG, Olympus Corporation, Fujifilm Holdings Corporation, Biovision Veterinary Endoscopy, LLC, Dr. Fritz GmbH, Eickemeyer Veterinary Equipment Ltd., B. Braun Melsungen AG, and STERIS Corporation. These firms lead in developing advanced endoscopic systems with AI and high-definition imaging. The report includes a detailed competition dashboard, benchmarking, and market share analysis, highlighting strategies such as product development, strategic partnerships, and regional expansion. As the market evolves, these players are well-positioned to capitalize on opportunities in minimally invasive diagnostics and livestock health management.

Strategic Recommendations and Future Implications

Fact.MR’s report offers actionable recommendations, urging stakeholders to invest in cost-effective, portable endoscopic solutions and AI-driven diagnostics to enhance accessibility. Providers should prioritize training programs to address skill gaps and expand in high-growth regions like Asia-Pacific. The study includes value chain analysis, PESTLE factors, and SWOT assessments to support strategic decision-making. As pet ownership and livestock production rise, veterinary endoscopy will remain a cornerstone of modern animal healthcare, improving diagnostic precision and animal welfare globally.

Fact.MR delivers comprehensive market reports and valuable business insights, uncovering trends, growth paths, and competitive landscapes. Committed to accuracy and reliability, Fact.MR empowers businesses with critical data and strategic recommendations, enhancing market positioning. With a global presence and experienced analysts,

Fact.MR ensures reliable market intelligence, equipping clients to capitalize on opportunities. For more information, visit https://www.factmr.com/report/veterinary-endoscopy-market